Cannabis 101

Cannabis and Pain: What to Know About Formats and Evidence

What major reviews found on cannabis and chronic pain, how each format differs in timing, how to read a label and how to keep a log your clinician can use.

Cannabis for pain is a common question: the National Academies called chronic pain by far the most common condition patients cite for medical use. The honest summary of the research is "modest." Major reviews report small to moderate improvements in pain for some adults living with chronic pain, mostly in short studies and alongside side effects. How you take cannabis also shapes when it starts and how long it lasts, so the format deserves as much thought as the product. Here's what the evidence says, how the formats compare and which habits keep things careful and well documented.

What research says about cannabis for pain

The strongest research concerns chronic pain in adults. Three reviews anchor the discussion:

  • The National Academies (2017). A committee of the National Academies of Sciences, Engineering, and Medicine concluded there is substantial evidence that cannabis is effective for chronic pain in adults, while describing the effect as modest. Most of the trials behind that conclusion studied nabiximols, a mouth spray, outside the United States. Only a handful of U.S. studies had tested cannabis flower, and the committee noted that many products in state markets bear little resemblance to the ones used in research.
  • The BMJ guideline (2021). An international panel found small to very small improvements in pain intensity, physical functioning and sleep quality with non-inhaled medical cannabis. Because benefits and harms were closely balanced, it issued only a weak recommendation: clinicians could offer a trial alongside standard care when standard care isn't enough.
  • A federally funded review (2022). Researchers supported by the U.S. Agency for Healthcare Research and Quality found that most studies ran one to six months. Some products may be associated with short-term improvements in pain, along with more dizziness and sedation.

Taken together, the research supports a careful conversation with your clinician, not a promise. To see how pain compares with other areas of study, read what the research says about cannabis benefits.

Formats compared: edibles, inhaled, topicals, tinctures and capsules

Format changes timing more than anything else, and timing matters when you're planning a day.

FormatWhen it startsNotes
Edibles and capsulesHalf an hour to 2 hours, with the peak as late as 4 hoursSlow to start and long-lasting; taking more too soon is the classic mistake
Flower and vapesWithin minutes, peaking by roughly the half-hour markQuick and easy to pace, though the BMJ guideline's recommendation covered non-inhaled products only
TopicalsVariesMeant to act where they're applied; human studies are few
TincturesVaries with how you take themOften labeled in mg per mL, so small, repeatable servings are possible
High-potency oilsLike an edible when swallowedA few drops can hold a lot of THC; measure precisely

A closer look at the less familiar formats:

  • Topicals such as lotions and balms go on the skin. Researchers are interested because cannabinoids applied locally might sidestep the whole-body side effects of eating or inhaling cannabis. Still, a 2022 systematic review turned up just six human studies of topical cannabinoids for pain, with most of its data coming from animal research. Our topicals guide explains how they're made and used.
  • Tinctures come with a dropper, which makes measured, repeatable amounts easy. The math is in our cannabis tincture guide.
  • High-potency oils, including full-extract oils, concentrate a lot of THC into very little liquid. Read our guide to RSO labels and types and talk with your clinician before considering one.

THC versus CBD in pain research

The 2022 federally funded review grouped products by their ratio of THC to CBD, which makes the comparison clearer:

  • THC-dominant: synthetic products that were almost pure THC may be associated with moderate short-term improvement in pain, plus a higher risk of sedation and a large increase in the risk of dizziness.
  • Balanced: a mouth spray with roughly equal parts THC and CBD was probably associated with small improvements in pain and function, plus more dizziness, sedation and nausea.
  • CBD-dominant and everything else: the evidence was insufficient to judge.

In short, the products with the most research behind them contain THC and come with intoxicating side effects. CBD on its own hasn't been studied enough in pain to say much either way.

Routine habits: a comfortable setting, gentle movement, consistent timing

Habits don't change what a product does, but they make your experience easier to read:

  • Choose a calm setting. Use cannabis at home, when you have nowhere to drive and no big decisions ahead.
  • Keep up the movement your care team recommends. Cannabis shouldn't replace the stretching, physical therapy or other activity your clinician suggests.
  • Stay consistent. Same product, similar time of day, so you can tell what's making a difference and what isn't.
  • Start small. Health Canada's lower-risk tips set the opening amount at 2.5 mg of THC or less for an edible, or one to two inhalations when the product is 10% THC or weaker. Change only one variable per session.

Label literacy: ratios, mg per serving, onset notes

The label is where careful use begins. Look for three things:

  1. The ratio. A 1:1 product contains equal milligrams of THC and CBD. With other ratios, check which cannabinoid comes first: 20:1 CBD to THC is mostly CBD, while 20:1 THC to CBD is mostly THC. The ratio hints at how intoxicating a product is likely to be.
  2. Serving versus package. Package totals can look big. Split the total across the servings listed to see what one piece or one dropper actually holds.
  3. Onset. Every Michigan label has to show the THC and CBD content and an activation time. Use that note, plus the format, to decide how long to wait before taking more.

If a label leaves you unsure, our budtenders can walk through it with you; questions about your pain itself belong with your clinician.

Combining formats carefully

Combining formats is where people most often overshoot. The textbook case: an edible seems to do nothing after an hour, so a vape session follows, and then both peak at the same time.

  • Add up the milligrams from every format in a session.
  • Let slow formats finish. Give an edible up to 4 hours to reach its peak before you add anything.
  • Change one thing at a time. If you introduce a topical or tincture, keep the rest of your routine the same that week.
  • Skip alcohol. Mixing substances makes effects harder to predict.

A symptom-and-dose log to share with your clinician

A simple log gives your clinician real information instead of guesses. Write one line per session, using columns like these:

ColumnWhat to write
Date and timeWhen you used cannabis
Product and formatFor example, a tincture under the tongue or an edible
THC and CBDMilligrams of each, from the label
Pain beforeYour rating from 0 to 10
Pain laterYour rating about 2 hours afterward
SleepHow you slept that night
Side effectsDizziness, drowsiness or anything unusual

Bring a few weeks of entries to your next appointment. The log shows what you're taking, how often and what you've noticed, which makes for a better conversation about your overall care.

When to see a doctor, and Michigan's medical card

See a doctor if your pain is new, severe or getting worse, if it keeps you from daily life, or before you combine cannabis with other medicines. Keep taking your medication as directed, and don't change it without your clinician's input.

Chronic pain is one of the qualifying conditions for a Michigan medical marijuana card. So is a chronic or debilitating disease or medical condition, or its treatment, that produces severe and chronic pain. A Michigan-licensed physician must certify the condition, and from age 18 you can register as a patient yourself. Our step-by-step card guide walks through applying, and our resources for registered patients explain what comes next.

Frequently asked questions

Is cannabis effective for chronic pain?

Research suggests a modest effect for some adults. The National Academies found substantial evidence of effectiveness for chronic pain while calling the effect modest, and a 2021 BMJ guideline found small to very small gains in pain, function and sleep with non-inhaled products. Most studies were short and used pharmaceutical products, so talk with your clinician about your own situation.

Do topicals work for pain?

The evidence is thin. A 2022 systematic review found only six human studies of topical cannabinoids for pain, one randomized trial and five case reports or series, while most of its data came from animals. The human results were preliminary. Topicals are designed to act where they're applied, so keep expectations modest and mention it to your clinician if you try one.

Is THC or CBD better for pain?

Neither stands out on its own. A 2022 review linked nearly pure THC products and a balanced THC and CBD spray with short-term improvements in some trials, along with dizziness and sedation. For CBD-heavy products, the evidence was too limited to judge. Your clinician can help you weigh those trade-offs against the rest of your care.

Is chronic pain a qualifying condition in Michigan?

Yes. Chronic pain is on Michigan's list of qualifying conditions, and so is a chronic or debilitating condition that produces severe and chronic pain. A Michigan-licensed physician must certify it, and once you're 18 you can register as a patient yourself, with no parent or guardian involved. Our medical card guide explains each step of the process.

Sources

  1. National Academies of Sciences, Engineering, and Medicine (2017), The Health Effects of Cannabis and Cannabinoids, chapter 4: therapeutic effectsnationalacademies.org
  2. Busse et al. (2021), medical cannabis or cannabinoids for chronic pain: a clinical practice guideline, BMJpubmed.ncbi.nlm.nih.gov
  3. McDonagh et al. (2022), cannabis-based products for chronic pain: a systematic review (funded by the Agency for Healthcare Research and Quality), Annals of Internal Medicinepubmed.ncbi.nlm.nih.gov
  4. Linde et al. (2022), efficacy of topical cannabinoids in the management of pain: a systematic review and meta-analysis of animal studies, with a narrative summary of six human studies, Regional Anesthesia and Pain Medicinepubmed.ncbi.nlm.nih.gov
  5. Health Canada: Cannabis, lower your riskscanada.ca
  6. Michigan Cannabis Regulatory Agency: What medical conditions are eligible?michigan.gov

Michigan's medical card, explained

Michigan's medical marijuana program has its own card and its own rules for patients and caregivers. Our guides explain how to apply and walk through the main product types. For questions about your health, talk with your doctor.

ORDER NOW CONTACT US